
Pasithea Therapeutics Corp.
KTTANASDAQHealthcareBiotechnology
أحدث البيانات المتاحة
0.4675 US$
+0.0266 US$ · +6.03%
KTTA نظرة عامة على الشركة
ملف الشركة
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.













